Provided by Tiger Fintech (Singapore) Pte. Ltd.

Skye Bioscience Inc.

1.57
+0.13509.41%
Post-market: 1.600.0300+1.91%19:14 EDT
Volume:567.97K
Turnover:848.28K
Market Cap:48.63M
PE:-2.15
High:1.58
Open:1.40
Low:1.36
Close:1.44
Loading ...
Mar 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Dec 24, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Major Issues Report

Form 8-K - Current report
Oct 24, 2024

Major Issues Report

Form 8-K - Current report
Sep 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 03, 2024

Major Issues Report

Form 8-K - Current report